Home Healthcare Biotechnology Oral Proteins And Peptides Market

Oral Proteins And Peptides Market Size, Share & Trends Analysis Report By Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide, Others), By Molecule Type (Proteins, Peptides), By Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, Cancer, Others), By End-User (Hospitals, Clinics, Homecare Settings, Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Oral Proteins And Peptides Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Linaclotide
    2. Plecanatide
    3. Calcitonin
    4. Insulin
    5. Octreotide
    6. Others
  2. Oral Proteins And Peptides Market, By Molecule Type 2022-2034 (USD MILLION/ Units)
    1. Proteins
    2. Peptides
  3. Oral Proteins And Peptides Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Gastric and Digestive Disorders
    2. Bone Diseases
    3. Diabetes
    4. Hormonal Disorders
    5. Cancer
    6. Others
  4. Oral Proteins And Peptides Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Clinics
    3. Homecare Settings
    4. Research Institutes
    5. Others
  5. Regional Oral Proteins And Peptides Market
    1. North America
      1. North America Oral Proteins And Peptides Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      2. North America Oral Proteins And Peptides Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      3. North America Oral Proteins And Peptides Market By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      4. North America Oral Proteins And Peptides Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
      5. U.S.
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      6. Canada
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
    2. Europe
      1. Europe Oral Proteins And Peptides Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      2. Europe Oral Proteins And Peptides Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      3. Europe Oral Proteins And Peptides Market By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      4. Europe Oral Proteins And Peptides Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
      5. U.K.
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      6. Germany
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      7. France
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      8. Spain
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      9. Italy
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      10. Russia
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      11. Nordic
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      12. Benelux
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      13. Rest of Europe
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
    3. APAC
      1. APAC Oral Proteins And Peptides Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      2. APAC Oral Proteins And Peptides Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      3. APAC Oral Proteins And Peptides Market By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      4. APAC Oral Proteins And Peptides Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
      5. China
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      6. Korea
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      7. Japan
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      8. India
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      9. Australia
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      10. Taiwan
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      11. South East Asia
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      12. Rest of Asia-Pacific
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
    4. Middle East and Africa
      1. Middle East and Africa Oral Proteins And Peptides Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      2. Middle East and Africa Oral Proteins And Peptides Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      3. Middle East and Africa Oral Proteins And Peptides Market By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      4. Middle East and Africa Oral Proteins And Peptides Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
      5. UAE
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      6. Turkey
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      7. Saudi Arabia
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      8. South Africa
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      9. Egypt
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      10. Nigeria
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      11. Rest of MEA
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
    5. LATAM
      1. LATAM Oral Proteins And Peptides Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
      2. LATAM Oral Proteins And Peptides Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. Proteins
        2. Peptides
      3. LATAM Oral Proteins And Peptides Market By Application 2022-2034 (USD MILLION/ Units)
        1. Gastric and Digestive Disorders
        2. Bone Diseases
        3. Diabetes
        4. Hormonal Disorders
        5. Cancer
        6. Others
      4. LATAM Oral Proteins And Peptides Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Homecare Settings
        4. Research Institutes
        5. Others
      5. Brazil
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      6. Mexico
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      7. Argentina
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      8. Chile
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      9. Colombia
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
      10. Rest of LATAM
        1. Linaclotide
        2. Plecanatide
        3. Calcitonin
        4. Insulin
        5. Octreotide
        6. Others
        7. Proteins
        8. Peptides
        9. Gastric and Digestive Disorders
        10. Bone Diseases
        11. Diabetes
        12. Hormonal Disorders
        13. Cancer
        14. Others
        15. Hospitals
        16. Clinics
        17. Homecare Settings
        18. Research Institutes
        19. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.